Octagon Therapeutics
Biotechnology Research • 
Providence, Rhode Island, United States • 1-10 Employees
Company overview
| Headquarters | Providence, Rhode Island, United States |
| Phone number | +17819108518 |
| Websites | |
| NAICS | 541714 |
| Keywords | Drug Discovery, Drug Development, High Throughput Screening, Autoimmunity, Inflammation |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at Octagon Therapeutics
Brent Cezairliyan
Vice President of Biology
About Octagon Therapeutics
Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes.
$
Octagon Therapeutics revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
Vice President
Employees by Department
Octagon Therapeutics has 2 employees across 1 departments.
Departments
Number of employees
United Kingdom
New Zealand
Hong Kong
Ireland
Frequently asked questions
Octagon Therapeutics is located in Providence, Rhode Island, US.
You can reach Octagon Therapeutics at +17819108518.
Octagon Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.
Octagon Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
